Sector: Health Care
Director information for GUARDANT HEALTH INC (data for year 2026)
| Name | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| Alex M. Azar II | Director; 24th Secretary of the U.S. Department of Health and Human Services | 58 | ["24th Secretary of the U.S. Department of Health and Human Services (2018-2021)","President of Lilly USA, LLC (2007-2017)","Deputy Secretary of HHS (2005-2007)","General Counsel of HHS (2001-2005)","Partner at Wiley Rein LLP (1999-2001)","Adjunct Professor of Business and Distinguished Executive-in-Residence at the University of Miami Herbert Business School"] | ["Nominating and Corporate Governance Committee"] | 2026 |
| AmirAli Talasaz | Director & Co-CEO; Co-Chief Executive Officer | 46 | ["Co-founder of Guardant Health, Inc.","Former Chairperson of the Board","Former President and COO","Senior Director of Diagnostics Research at Illumina, Inc.","Founder of Auriphex Biosciences, Inc.","Ph.D. degree in electrical engineering from Stanford University"] | [] | 2026 |
| AmirAli Talasaz, Ph.D. | Co-Chief Executive Officer | 46 | [] | [] | 2026 |
| Helmy Eltoukhy | Chair & Co-Chief Executive Officer (“Co-CEO”) | 47 | ["Co-founder of Guardant Health, Inc.","CEO since January 2013","Held positions at Illumina, Inc. including Senior Director of Advanced Technology Research","Co-founded Avantome Inc.","Post-doctoral fellow at Stanford Genome Technology Center","Ph.D., M.S. and B.S. in electrical engineering from Stanford University"] | [] | 2026 |
| Helmy Eltoukhy, Ph.D. | Chairperson and Co-Chief Executive Officer | 47 | [] | [] | 2026 |
| Ian Clark | Lead Independent Director; Chair | 65 | ["Former Chief Executive Officer of Genentech Inc.","14 years at Genentech including 12 on the Executive Committee","20 years in positions of increasing responsibility at Novartis, Sanofi, Ivax, and Searle","Advisor to KKR and previously at Lazard, Blackstone Life Sciences, and Perella Weinberg Partners","Served on the Board of the Biotechnology Industry Organization (BIO)","Member of the 12th District Economic Advisory Council (EAC) of the Federal Reserve","Chair of the External Advisory Board to Southampton University’s Institute for Life Sciences","B.Sc. and honorary doctorate in biological sciences from Southampton University"] | ["Nominating and Corporate Governance Committee (Chair)"] | 2026 |
| Manuel Hidalgo Medina | Director of GI Cancer Center and Professor of Medicine at New York University | 58 | ["Director of the GI Cancer Center at NYU since 2025","Professor of Medicine at NYU since 2025","Chief of the division of hematology and medical oncology at Weill Cornell Medicine from 2019 to 2025","Chief of hematology and medical oncology at Beth Israel Deaconess Medical Center from 2015 to 2019","Theodore W. and Evelyn G. Berenson professor of medicine at Harvard Medical School","Leadership positions at the Spanish National Cancer Research Centre (CNIO) in Madrid","Director of gastrointestinal oncology program at Kimmel Comprehensive Cancer Center"] | ["Nominating and Corporate Governance Committee"] | 2026 |
| Meghan Joyce | [] | [] | 2026 | ||
| Meghan Joyce(1) | Director | 42 | [] | [] | 2026 |
| Musa Tariq | Director; Former Chief Marketing Officer of GoFundMe | 43 | ["Founder of Science x Story","Former Chief Marketing Officer of GoFundMe","Global Head of Marketing for Airbnb Experiences","Chief Brand Officer at Ford Motor Company","Held marketing leadership roles at Apple, Nike and Burberry","B.S. in Geography and Economics from London School of Economics"] | ["Nominating and Corporate Governance Committee"] | 2026 |
| Myrtle Potter | Director; Former President, Chief Executive Officer and Chairperson of Sumitomo Pharma America, Inc. | 67 | ["Experience in the biotechnology industry","Extensive commercial and operational experience leading pharmaceutical companies","Experience serving on boards of public companies"] | ["Audit Committee","Compensation Committee"] | 2026 |
| Roberto Mignone | Director; Founder and Managing Partner of Bridger Management LLC | 54 | ["Founder and Managing Partner of Bridger Management LLC","Co-founder and partner of Blue Ridge Capital LLC","Board of Directors at Teva Pharmaceuticals","Co-Vice Chair at the New York University Langone Medical Center","Served on the Board of Directors of Avanti Acquisition","Bachelor of Arts degree in Classics from Harvard College","Master of Business Administration degree from Harvard Business School","Long career as a global investment professional focused on healthcare","Finance and management expertise with respect to large, complex pharmaceutical organizations"] | ["Audit Committee"] | 2026 |
| Steve Krognes | Director; Chair; Former Chief Financial Officer | 57 | ["professional independent board member in the biotech and life sciences sector","Chief Financial Officer at Denali Therapeutics Inc.","Chief Financial Officer and member of the Executive Committee at Genentech, Inc.","oversaw Genentech’s Site Services and IT organizations","Head of Mergers & Acquisitions and member of the Finance Executive Committee at Roche Holding AG","Director of M&A at Danske Bank"] | ["Audit Committee (Chair)"] | 2026 |
| Vijaya Gadde | Director; Chair; Former Chief Legal Officer of Twitter, Inc. | 51 | ["Former Chief Legal Officer of Twitter, Inc.","Led legal, public policy, and trust and safety teams globally","General Counsel of Twitter, Inc.","Senior Director, Legal at Juniper Networks","Attorney at Wilson Sonsini Goodrich & Rosati","Board of Trustees of NYU Law School","Board of Directors of Planet Labs PBC","Co-founded #Angels"] | ["Compensation Committee (Chair)"] | 2026 |
